|

Eltanexor Clinical Trials

1 actively recruiting trial across 1 location

Also known as: KPT-8602

Pipeline

Phase 1: 1

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1

Indications

  • Relapsed Myelodysplastic Syndrome1
  • Refractory Myelodysplastic Syndrome1
  • Refractory Acute Myeloid Leukemia1
  • Recurrent Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia1

Nashville, Tennessee1 trial

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Vanderbilt University/Ingram Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.